Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05883644
Title Durvalumab and Tremelimumab as First Line Treatment in Participants With Advanced Hepatocellular Carcinoma (HCC) (SIERRA)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ITA | FRA | ESP | DEU

Facility Status City State Zip Country Details
Research Site NOT_YET_RECRUITING La Jolla California 92093 United States Details
Research Site RECRUITING Shreveport Louisiana 71103 United States Details
Research Site RECRUITING Detroit Michigan 48202 United States Details
Research Site NOT_YET_RECRUITING Bobigny 93000 France Details
Research Site RECRUITING Clichy 92110 France Details
Research Site NOT_YET_RECRUITING Creteil 94010 France Details
Research Site NOT_YET_RECRUITING Lyon 69004 France Details
Research Site NOT_YET_RECRUITING Marseille 13005 France Details
Research Site RECRUITING Rennes 35000 France Details
Research Site RECRUITING Berlin D-13353 Germany Details
Research Site RECRUITING Frankfurt 60488 Germany Details
Research Site RECRUITING Kiel 24105 Germany Details
Research Site NOT_YET_RECRUITING Köln 50937 Germany Details
Research Site NOT_YET_RECRUITING Magdeburg 39120 Germany Details
Research Site NOT_YET_RECRUITING Mainz 55131 Germany Details
Research Site RECRUITING Hong Kong 0000 Hong Kong Details
Research Site NOT_YET_RECRUITING Hong Kong 0000 Hong Kong Details
Research Site RECRUITING Shatin 00000 Hong Kong Details
Research Site RECRUITING Milano 20132 Italy Details
Research Site NOT_YET_RECRUITING Napoli 80147 Italy Details
Research Site NOT_YET_RECRUITING Padova 35128 Italy Details
Research Site RECRUITING Pisa 56126 Italy Details
Research Site RECRUITING Rozzano 20089 Italy Details
Research Site RECRUITING Turin 10128 Italy Details
Research Site RECRUITING Chiba-shi 260-8677 Japan Details
Research Site WITHDRAWN Chuo-ku 104-0045 Japan Details
Research Site RECRUITING Kanazawa-shi 920-8641 Japan Details
Research Site RECRUITING Kashiwa 277-8577 Japan Details
Research Site RECRUITING Kyoto-shi 602-8566 Japan Details
Research Site RECRUITING Matsuyama-city 790-0024 Japan Details
Research Site RECRUITING Musashino-shi 180-8610 Japan Details
Research Site RECRUITING Osakasayama-shi 589-8511 Japan Details
Research Site RECRUITING Yokohama-shi 241-8515 Japan Details
Research Site RECRUITING Gyeonggi-do 13620 Korea, Republic of Details
Research Site RECRUITING Seongnam-si 13496 Korea, Republic of Details
Research Site RECRUITING Seoul 03080 Korea, Republic of Details
Research Site RECRUITING Seoul 03722 Korea, Republic of Details
Research Site RECRUITING Seoul 05505 Korea, Republic of Details
Research Site RECRUITING Seoul 06351 Korea, Republic of Details
Research Site RECRUITING Singapore 119228 Singapore Details
Research Site RECRUITING Singapore 169610 Singapore Details
Research Site RECRUITING Singapore 308433 Singapore Details
Research Site RECRUITING Barcelona 08036 Spain Details
Research Site RECRUITING Barcelona 8035 Spain Details
Research Site RECRUITING Cordoba 14004 Spain Details
Research Site NOT_YET_RECRUITING Madrid 28007 Spain Details
Research Site RECRUITING Madrid 28040 Spain Details
Research Site RECRUITING Pamplona 31008 Spain Details
Research Site NOT_YET_RECRUITING Hanoi 100000 Vietnam Details
Research Site NOT_YET_RECRUITING Ho Chi Minh 700000 Vietnam Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field